BR112021003480A2 - processos para a preparação de 4-{8-amino-3-[(2s)-1-(but-2-inoil)-pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)-benzamida - Google Patents
processos para a preparação de 4-{8-amino-3-[(2s)-1-(but-2-inoil)-pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)-benzamida Download PDFInfo
- Publication number
- BR112021003480A2 BR112021003480A2 BR112021003480-3A BR112021003480A BR112021003480A2 BR 112021003480 A2 BR112021003480 A2 BR 112021003480A2 BR 112021003480 A BR112021003480 A BR 112021003480A BR 112021003480 A2 BR112021003480 A2 BR 112021003480A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formula
- salt
- vii
- modality
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724228P | 2018-08-29 | 2018-08-29 | |
| US62/724,228 | 2018-08-29 | ||
| PCT/EP2019/072991 WO2020043787A1 (en) | 2018-08-29 | 2019-08-28 | Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021003480A2 true BR112021003480A2 (pt) | 2021-05-18 |
Family
ID=67928802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021003480-3A BR112021003480A2 (pt) | 2018-08-29 | 2019-08-28 | processos para a preparação de 4-{8-amino-3-[(2s)-1-(but-2-inoil)-pirrolidin-2-il]imidazo[1,5-a]-pirazin-1-il}-n-(piridin-2-il)-benzamida |
Country Status (16)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| EP3947386A1 (en) * | 2019-03-27 | 2022-02-09 | Assia Chemical Industries Ltd | Solid state forms of acalabrutinib |
| DK4054582T3 (da) | 2019-11-04 | 2025-12-01 | Astrazeneca Ab | Terapeutiske kombinationer af acalabrutinib og capivasertib til behandling af b-celle-maligniteter |
| CR20230018A (es) | 2020-06-19 | 2023-04-11 | Acerta Pharma Bv | Formas farmacéuticas de maleato de acalabrutinib |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2372694T3 (es) | 2003-10-15 | 2012-01-25 | OSI Pharmaceuticals, LLC | Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina. |
| EP2139487B1 (en) | 2007-03-28 | 2015-11-11 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
| US8765754B2 (en) | 2009-04-29 | 2014-07-01 | Locus Pharmaceuticals, Inc. | Pyrrolotriazine compounds |
| US8658794B2 (en) | 2010-02-08 | 2014-02-25 | Merck Sharp & Dohme B.V. | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof |
| CN103889987B (zh) * | 2011-07-19 | 2016-09-14 | 默沙东有限责任公司 | 作为btk抑制剂的选择的咪唑并吡嗪类 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| WO2014113942A1 (en) | 2013-01-23 | 2014-07-31 | Merck Sharp & Dohme Corp. | Btk inhibitors |
| MX362181B (es) | 2013-02-19 | 2019-01-08 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa del receptor de tropomiosina (trk). |
| US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| WO2016128912A1 (en) | 2015-02-12 | 2016-08-18 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, a pd-1 inhibitor, and/or a pd-l1 inhibitor |
| IL293821A (en) | 2015-07-02 | 2022-08-01 | Acerta Pharma Bv | Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-aminoyl)pyrrolidine-2-yl)imidazo[5,1-yl]pyrazin-1-yl)-en- (pyridine-2-yl)benzamide |
| WO2017077507A1 (en) * | 2015-11-06 | 2017-05-11 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of bruton's tyrosine kinase |
| CN107056786B (zh) | 2016-10-14 | 2019-05-07 | 苏州明锐医药科技有限公司 | 阿卡替尼的制备方法 |
| ES2856248T3 (es) | 2016-12-21 | 2021-09-27 | Acerta Pharma Bv | Inhibidores de imidazopirazina de la tirosina quinasa de Bruton |
| WO2018115965A1 (en) * | 2016-12-23 | 2018-06-28 | Acerta Pharma Bv | Solid forms of imidazopyrazine compounds |
| CN106588937B (zh) | 2017-01-16 | 2018-09-21 | 东莞市真兴贝特医药技术有限公司 | 咪唑并吡嗪类化合物及其制备方法和应用 |
| US10899770B2 (en) | 2017-02-20 | 2021-01-26 | Hangzhou Solipharma Co., Ltd. | Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof |
| US10800787B2 (en) | 2017-04-20 | 2020-10-13 | Apotex Inc. | Process for the preparation of acalabrutinib |
| CN107522701B (zh) | 2017-09-01 | 2019-11-08 | 苏州富士莱医药股份有限公司 | 一种治疗慢性淋巴细胞白血病的BTK抑制剂Acalabrutinib的合成方法 |
| US11161851B2 (en) | 2017-11-06 | 2021-11-02 | Suzhou Pengxu Pharmatech Co. Ltd. | Processes to produce acalabrutinib |
| CN108250186B (zh) * | 2018-02-07 | 2020-01-14 | 杭州科巢生物科技有限公司 | Acalabrutinib及其中间体的合成方法 |
| WO2019239374A1 (en) | 2018-06-13 | 2019-12-19 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of interleukin-2-inducible t-cell kinase |
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| WO2020085504A1 (ja) | 2018-10-26 | 2020-04-30 | 大鵬薬品工業株式会社 | 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法 |
-
2019
- 2019-08-28 KR KR1020257025628A patent/KR20250119664A/ko active Pending
- 2019-08-28 BR BR112021003480-3A patent/BR112021003480A2/pt unknown
- 2019-08-28 IL IL281025A patent/IL281025B2/en unknown
- 2019-08-28 CN CN201980055726.6A patent/CN112638878B/zh active Active
- 2019-08-28 KR KR1020217008606A patent/KR102842131B1/ko active Active
- 2019-08-28 IL IL312413A patent/IL312413B2/en unknown
- 2019-08-28 EA EA202190557A patent/EA202190557A1/ru unknown
- 2019-08-28 EP EP19766195.2A patent/EP3844149A1/en active Pending
- 2019-08-28 CN CN202510979992.5A patent/CN120904205A/zh active Pending
- 2019-08-28 MA MA053485A patent/MA53485A/fr unknown
- 2019-08-28 MY MYPI2021000982A patent/MY206899A/en unknown
- 2019-08-28 CA CA3109734A patent/CA3109734A1/en active Pending
- 2019-08-28 WO PCT/EP2019/072991 patent/WO2020043787A1/en not_active Ceased
- 2019-08-28 MX MX2021002246A patent/MX2021002246A/es unknown
- 2019-08-28 JP JP2021536157A patent/JP7439095B2/ja active Active
- 2019-08-28 US US17/271,750 patent/US12024520B2/en active Active
- 2019-08-28 AU AU2019332882A patent/AU2019332882B2/en active Active
- 2019-08-28 IL IL322382A patent/IL322382A/en unknown
-
2021
- 2021-02-25 MX MX2023011692A patent/MX2023011692A/es unknown
- 2021-03-23 CO CONC2021/0003676A patent/CO2021003676A2/es unknown
-
2022
- 2022-02-09 AU AU2022200828A patent/AU2022200828B2/en active Active
-
2023
- 2023-06-20 ZA ZA2023/06381A patent/ZA202306381B/en unknown
- 2023-07-13 AU AU2023204660A patent/AU2023204660B2/en active Active
- 2023-12-18 JP JP2023212753A patent/JP7829541B2/ja active Active
-
2024
- 2024-04-10 AU AU2024202290A patent/AU2024202290A1/en not_active Abandoned
- 2024-05-09 US US18/659,338 patent/US12448387B2/en active Active
- 2024-12-09 ZA ZA2024/09391A patent/ZA202409391B/en unknown
-
2025
- 2025-09-12 US US19/326,835 patent/US20260109701A1/en active Pending
- 2025-10-21 JP JP2025176881A patent/JP2026021364A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2684641C1 (ru) | Производные пиразолопиридина в качестве модуляторов активности tnf | |
| US12448387B2 (en) | Processes for the preparation of 4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yljimidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide | |
| AU2010233952B2 (en) | Anthelmintic agents and their use | |
| RU2677697C1 (ru) | Производные триазолопиридина в качестве модуляторов активности tnf | |
| RU2677698C1 (ru) | Производные триазолопиридазина в качестве модуляторов активности tnf | |
| EP1274709A1 (de) | Salze von bicyclischen, n-acylierten imidazo-3-aminen und imidazo-5-aminen | |
| ES2345207T3 (es) | Compuestos pirazolo-heteroarilicos utiles para tratar enfermedades mediadas por tnf-alfa e il-1. | |
| JP2011519897A (ja) | 変性及び炎症性疾患の治療に有用な融合ピラジン化合物 | |
| AU2016214802B2 (en) | Diaza-benzofluoranthrene compounds | |
| EA043329B1 (ru) | СПОСОБЫ ПОЛУЧЕНИЯ 4-{8-АМИНО-3-[(2S)-1-(БУТ-2-ИНОЛ)ПИРРОЛИДИН-2-ИЛ]ИМИДАЗО[1,5-a]ПИРАЗИН-1-ИЛ}-N-(ПИРИДИН-2-ИЛ)БЕНЗАМИДА | |
| EA049170B1 (ru) | СПОСОБ ПОЛУЧЕНИЯ 4-{8-АМИНО-3-[(2S)-2-ПИРРОЛИДИНИЛ]ИМИДАЗО[1,5-a]ПИРАЗИН-1-ИЛ}-N-(2-ПИРИДИНИЛ)БЕНЗАМИДА | |
| JP5536771B2 (ja) | セロトニン作動性活性を有する化合物、その製造方法およびそれを含む医薬組成物 | |
| IL312472A (en) | Evaluation system, evaluation method and evaluation software | |
| HK40041702B (en) | Processes for the preparation of acalabrutinib | |
| WO2024059220A2 (en) | 6,5 southwestern core compounds as mglu5 negative allosteric modulators and methods of making and using the same | |
| JP2024534382A (ja) | mGlu5ネガティブアロステリックモジュレーターとしてのフェニルコア化合物並びにこの製造方法及び使用方法 | |
| WO2025009477A1 (ja) | 3-メチル-1,2,4-チアジアゾール-5-カルボヒドラジドの新規製造方法 | |
| CN103228656A (zh) | 3-取代基-6-(吡啶基甲氧基)-吡咯并吡啶化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B154 | Notification of filing of divisional application [chapter 15.50 patent gazette] |
Free format text: O PEDIDO FOI DIVIDIDO NO BR122023014328-0 PROTOCOLO 870230062597 EM 17/07/2023 16:45. |
|
| B154 | Notification of filing of divisional application [chapter 15.50 patent gazette] |
Free format text: O PEDIDO FOI DIVIDIDO NO BR122023016312-5 PROTOCOLO 870230071931 EM 14/08/2023 15:19. |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 213/75 , C07D 487/04 Ipc: C07D 213/75 (2006.01), C07D 487/04 (2006.01), A61P |